Peran Mutasi Gen BCR-Abl pada Perjalanan Klinis Pasien Leukemia Granulositik Kronik (LGK): Kaitannya dengan Aspek Terapi Imatinib Mesylate (IM) = The Role of BCR-Abl Gene Mutation in Clinical Course of Chronic Myeloid Leukemia Patients (CML): Relation to Aspects of Imatinib Mesylate Therapy (IM)

Penemuan inhibitor BCR-ABL terbarukan menggunakan penapisan virtual berbasis farmakofor dan simulasi dinamika molekul dalam terapi obat leukemia = Discovery of a novel BCR-ABL inhibitor using pharmacophore based virtual screening and molecular dynamics simulation in leukemia drug therapy

Hubungan Mutasi T315I Gen ABL1 dengan Pencapaian Major Molecular Response (MMR) pada Pasien Leukemia Granulositik Kronik Fase Kronik yang Mendapat Imatinib = Association between T315I Mutation in ABL1 Gene to the Achievement of Major Molecular Response (MMR) in Chronic Phase of Chronic Myeloid Leukemia Patients Treated with Imatinib

Hubungan ekspresi gen stat5a dan stat5b dengan pencapaian major molecular response (MMR) pada pasien leukemia granulositik kronik yang mendapat imatinib = Expression of stat5a and stat5b and its relation to achievement of major molecular response in patient with chronic phase chronic myeloid leukemia on imatinib treatment

Analisis praktik residensi keperawatan medikal bedah menggunakan penerapan teori peaceful end of life pada Pasien Akut Myeloid Leukemia (AML) di Rumah Sakit Kanker Dharmais, Jakarta = Analysis of Medical Surgical Residency Nursing Practice Apply Theory of Peaceful End of Life in Acute Myeloid Leukemia (AML) Patients in Dharmais Cancer Hospital Jakarta